Results 161 to 170 of about 380,200 (294)

ChatGPT-Assisted Image Interpretation for Inflammatory Bowel Diseases: Ulcerative Colitis and Crohn's Disease. [PDF]

JGH Open
Uekado H, Watanabe D, Aoyama Y, Kawase H, Ikeda S, Shiraki A, Pajimna J, Agawa M, Nakamura H, Ito Y, Okamoto N, Miyazaki H, Ku Y, Ooi M, Hoshi N, Kodama Y.   +15 more
europepmc   +1 more source

Gut Mycobiota‐Associated Tryptophan Catabolites Protect Against Metabolic Dysfunction‐Associated Steatotic Liver Disease

Advanced Science, EarlyView.
ABSTRACT Accumulating evidence suggests that the intestinal microbiota participates in the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD) through microbiota‐host interaction. However, the beneficial role of commensal mycobiota in MASLD progression remains poorly understood.
Shuping Qiao, Shuangya Fan, Juan Xu, Zhen Xu, Chen Peng, Junxing Qu, Ziqian Bing, Shizhen Zhou, Sunan Shen, Guifang Xu, Yue Zhao, Tingting Wang   +11 more
wiley   +1 more source

Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis. [PDF]

Med Sci (Basel)
Barton A, Labenz C, Grabbe S, Schattenberg JM, Kaps L, Kostev K.   +5 more
europepmc   +1 more source

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

Advanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong, Yuhang Xie, Zhijie Weng, Yongzhi Wu, Longjiang Li, Bo Li   +5 more
wiley   +1 more source

Hepatitis E Infection in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. [PDF]

J Viral Hepat
Kogias D, Kouklakis G, Papadopoulos V.
europepmc   +1 more source

Time‐Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism

Advanced Science, EarlyView.
This study established an RT‐MSCs‐based therapeutic approach for scleroderma in mice. RT‐MSCs attenuated fibrosis by regulating mitochondrial autophagy and restored gut microbiota homeostasis. Metabolomic analyses confirmed recovery of key metabolites, and RT‐MSCs demonstrated favorable lesion targeting and safety profiles.
Xue Xia, Chenfei Kong, Xiaoming Zhao, Naixu Shi, Jinlan Jiang, Ping Li   +5 more
wiley   +1 more source

Probing the activity of cysteine cathepsins in inflammatory bowel diseases. [PDF]

Sci Rep
Anderson BM, Ziegler AR, Campden RI, Wu H, Xu B, McQuade RM, Carbone SE, Poole DP, Lomax AE, Reed DE, Vanner SJ, Yates RM, Bunnett NW, Edgington-Mitchell LE.   +13 more
europepmc   +1 more source

Inflammatory Bowel Diseases [PDF]

Visceral Medicine, 2019
Wolfgang, Reindl, Anton J, Kroesen
openaire   +2 more sources

Rapid Remodeling of the Human Gut Microbiome in Response to Short‐Term Animal Product Restriction and Associations with Host Molecular Phenotypes

Advanced Science, EarlyView.
A real‐world model of structured animal product restriction practiced for religious reasons reveals the dynamic adaptability of the human gut microbiome to dietary change and uncovers reductions in diversity and rare taxa loss. Integrated microbiome, metabolomic, and proteomic analyses uncover coordinated taxonomic and molecular shifts and identify ...
Christina Emmanouil, Maria Anezaki, Alexandros Simistiras, Stavros Glentis, Nikolaos Scarmeas, Pantelis Hatzis, Konstantinos Rouskas, Antigone S. Dimas   +7 more
wiley   +1 more source

Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical Interactions. [PDF]

Metabolites
Fousekis F, Lamprou A, Saridi M, Mastorogianni IN, Mpakogiannis K, Lianos GD, Katsanos KH.   +6 more
europepmc   +1 more source